Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-07-2023 | Epstein-Barr Virus | Case report

Methotrexate

Reactivation of cutaneous Epstein-Barr virus-positive B cell lymphoproliferative disease: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Quaye EH, et al. Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate. Dermatology Online Journal 29: No. 1, Jan-Feb 2023. Available from: URL: http://doi.org/10.5070/D329160212 Quaye EH, et al. Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate. Dermatology Online Journal 29: No. 1, Jan-Feb 2023. Available from: URL: http://​doi.​org/​10.​5070/​D329160212
Metadata
Title
Methotrexate
Reactivation of cutaneous Epstein-Barr virus-positive B cell lymphoproliferative disease: case report
Publication date
01-07-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44037-7

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Adalimumab

Case report

Multiple drugs

Case report

Adalimumab

Case report

Ciprofloxacin